SA
Go ProLog In
IRON
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
11 analysts·Moderate coverage
77
Score
11 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
19%
Buy
1091%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$80.00
+19.7%
Consensus
$105.00
+57.0%
Bull
$125.00
+87.0%
12-Month Target Range11 analysts
$80.00$105.00$125.00
Current $66.86Consensus
Current Price
$66.86
Upside to Consensus
$38.14

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+920.47%
EPS—
FY2028
Rev+326.53%
EPS—
FY2029
Rev+158.65%
EPS—

Earnings Surprises

Recent Analyst Actions

May 14, 2026Morgan Stanley
Disc Medicine price target raised to $80 from $75 at Morgan Stanley
Target:$80.00
+15.4%from $69.30
Feb 17, 2026Wedbush
Disc Medicine price target lowered to $88 from $110 at Wedbush
Target:$88.00
+46.0%from $60.28
Feb 17, 2026Cantor Fitzgerald
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
Target:$125.00
+107.5%from $60.24
Feb 17, 2026Morgan Stanley
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
Target:$75.00
+24.2%from $60.39
Feb 17, 2026Stifel Nicolaus
Disc Medicine price target lowered to $110 from $125 at Stifel
Target:$110.00
+79.1%from $61.43
Feb 17, 2026BMO Capital
Disc Medicine price target lowered to $100 from $120 at BMO Capital
Target:$100.00
+62.7%from $61.48
Jan 8, 2026Morgan Stanley
Disc Medicine price target raised to $120 from $115 at Morgan Stanley
Target:$120.00
+48.3%from $80.94
Dec 8, 2025Raymond James
Disc Medicine (IRON) PT Raised to $117 at Raymond James
Target:$117.00
+21.5%from $96.32
Nov 10, 2025Truist Financial
Disc Medicine price target raised to $114 from $86 at Truist
Target:$114.00
+37.7%from $82.77
Oct 17, 2025National Bank
Disc Medicine price target raised to $153 from $132 at Cantor Fitzgerald
Target:$153.00
+62.4%from $94.19
Oct 17, 2025Raymond James
Disc Medicine price target raised to $108 from $89 at Raymond James
Target:$108.00
+45.2%from $74.36
Oct 17, 2025Wedbush
Disc Medicine price target raised to $110 from $90 at Wedbush
Target:$110.00
+47.9%from $74.36
Nov 5, 2024Scotiabank
Disc Medicine (IRON) PT Raised to $70 at Scotiabank
Target:$70.00
+8.1%from $64.78
Nov 5, 2024BMO Capital
Disc Medicine (IRON) PT Raised to $112 at BMO Capital
Target:$112.00
+77.1%from $63.24
Oct 23, 2024Jefferies
Jefferies Starts Disc Medicine (IRON) at Buy
Target:$89.00
+74.8%from $50.92
Sep 16, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)
Target:$70.00
+46.5%from $47.79
Aug 22, 2024Wells Fargo
Disc Medicine initiated with an Overweight at Wells Fargo
Target:$75.00
+52.1%from $49.31
Aug 8, 2024Raymond James
Disc Medicine (IRON) PT Raised to $50 at Raymond James
Target:$50.00
+16.7%from $42.85
Jun 17, 2024BMO Capital
Disc Medicine (IRON) PT Raised to $70 at BMO Capital
Target:$70.00
+52.8%from $45.80
May 10, 2024Raymond James
Disc Medicine price target raised to $43 from $40 at Raymond James
Target:$43.00
+43.6%from $29.95
Apr 2, 2024BMO Capital
Disc Medicine (IRON) PT Lowered to $50 at BMO Capital
Target:$50.00
+46.2%from $34.21
Apr 1, 2024Stifel Nicolaus
Disc Medicine (IRON) PT Lowered to $71 at Stifel
Target:$71.00
+107.5%from $34.21
Apr 1, 2024Wedbush
Disc Medicine (IRON) PT Lowered to $43 at Wedbush
Target:$43.00
+34.4%from $32.00
Apr 1, 2024Raymond James
Disc Medicine downgraded to Outperform from Strong Buy at Raymond James
Target:$40.00
+36.1%from $29.40

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance